CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$0.44 USD
+0.01 (1.84%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.44 0.00 (0.48%) 5:38 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CODX 0.44 +0.01(1.84%)
Will CODX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CODX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CODX
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates
CODX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Other News for CODX
Is CODX primed for upward momentum? Boomer Buy Setup shows up after advancing 3.09%
Tesla To Rally More Than 31%? Here Are 10 Top Analyst Forecasts For Friday
Co-Diagnostics (CODX) Analyst Rating Update: Target Price Lowered by 70% | CODX Stock News
Co-Diagnostics Announces $3.8M Securities Purchase Agreement
Is CODX preparing to trend higher? Jack-in-the-box Bullish shows up after crashing 34.71%